| Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) (NCT01421498) | Shire | 2011-08-29 |
| Diurnal Variation in Tear Osmolarity (NCT01321424) | Ophthalmic Consultants of Long Island | 2011-03-01 |
| Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients (NCT01276223) | Alcon Research | 2011-02-01 |
| Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL) (NCT01880463) | Brigham and Women's Hospital | 2010-07-01 |
| A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease (NCT01014078) | Merck Sharp & Dohme LLC | 2009-10-01 |
| The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) (NCT00831662) | Merck Sharp & Dohme LLC | 2009-01-01 |
| Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05% (NCT00827255) | Allergan | 2009-01-01 |
| Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® (NCT00799682) | Ophthalmic Consultants of Long Island | 2008-10-01 |
| The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients (NCT00718926) | Meiji University of Oriental Medicine | 2008-08-01 |
| Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease (NCT00667004) | Bausch & Lomb Incorporated | 2008-03-22 |
| Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634) (NCT00600288) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops (NCT00610480) | University of Texas Southwestern Medical Center | 2007-11-01 |
| Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase (NCT00520260) | Florida Eye Microsurgical Institute | 2007-08-01 |
| The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye Subjects (NCT00553579) | Southern California College of Optometry at Marshall B. Ketchum University | 2007-06-01 |
| Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome (NCT00599716) | Lantibio | 2006-12-01 |
| Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis (NCT00407043) | Ophthalmic Consultants of Long Island | 2006-11-01 |
| The Visual Effect of an Investigational Artificial Tear in the Tear Layer. (NCT00395759) | Southern California College of Optometry at Marshall B. Ketchum University | 2005-09-01 |
| Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease (NCT00403975) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT00404131) | Merck Sharp & Dohme LLC | 2001-03-01 |
| Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT00403715) | Merck Sharp & Dohme LLC | 2001-02-01 |
| A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease (NCT00679718) | Merck Sharp & Dohme LLC | 2000-01-01 |
| A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution (NCT00680108) | Merck Sharp & Dohme LLC | 1999-09-01 |